Prevalence of H. Pylori in Stomach Cancers in the West Indies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de la Guadeloupe
About this trial
The incidence and mortality of stomach cancer are higher in the French West Indies than in mainland France. The prevalence of H. pylori infection associated with this cancer remains unknown in these populations. The main objective of the study is to estimate the prevalence of H. Pylori detected by immunohistochemistry in patients newly diagnosed with cancer.
Eligibility criteria
Qualifiers
Patient over 18 years of age residing in Guadeloupe for more than 6 months and with a primary diagnosis of gastric cancer
Patient having read the information note and having signed the consent to participate in the study
Patient with social security coverage.
Disqualifiers
Refusal to participate.
Patient who could not answer the questionnaires
Patient not affiliated to a social security scheme
Patient under legal protection (judicial safeguard, guardianship, curatorship, etc.)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov